Literature DB >> 35015052

COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.

Jennifer Abbasi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35015052     DOI： 10.1001/jama.2021.24118

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  1 in total

1.  Cellular Immunity-The Key to Long-Term Protection in Individuals Recovered from SARS-CoV-2 and after Vaccination.

Authors:  Dragan Primorac; Petar Brlek; Vid Matišić; Vilim Molnar; Kristijan Vrdoljak; Renata Zadro; Marijo Parčina
Journal:  Vaccines (Basel)       Date:  2022-03-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.